Open original FDA record ↗Recall record
- FDA identifier
- Z-0734-2007
- Company in FDA record
- Roche Molecular Systems, Inc.
- FDA classification date
- Apr 11, 2007
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The current package insert for the AmpliChip CYP 450 test, lists an incorrect part number for DNase I. The DNase is listed in the "Other Materials Required" section as 'DNase I rec., RNase-free, P/N 04716728001 (Roche Applied Science)" . The Part Number listed for the DNase I listed is incorrect and of lower specific activity than the correct/validated DNase.
Source facts
- Action
- A product advisory notice was issued on March 9, 2007 to all affiliates, indentifying the problem and listing corrective actions followed by a customer letter (Urgent Medical Device Correction) issued on 3/21/2007, requesting several actions be performed including discontinued use of incorrect DNAse I.
- Initiated
- 2007-03-09
- Root cause
- Other
- Terminated
- 2007-08-23
- Distribution
- World wide Distribution --- USA including states of MI, IN, NC, CA KY, IN, VA, and FL.and countries of Netherlands, Germany, Sweden, Denmark, Italy, Spain, Belgium, Switzerland, and Hungary
- Recall number
- Z-0734-2007
- Recall status
- Terminated
- CDRH record ID
- 50895
- FDA classified
- 2007-04-11
- Recall event number
- 37585